General Information of the Compound
Compound ID |
CP0477896
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[(1-benzylsulfonylpiperidin-4-yl)methyl]-5-chloro-2-[1-[2-(3-oxo-1,4-benzoxazin-4-yl)ethyl]piperidin-4-yl]benzamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C35H41ClN4O5S
|
||||||||||||||||||
Molecular Weight |
665.256
|
||||||||||||||||||
Canonical SMILES |
Clc1ccc(C2CCN(CCN3C(=O)COc4ccccc34)CC2)c(c1)C(=O)NCC1CCN(CC1)S(=O)(=O)Cc1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C35H41ClN4O5S/c36-29-10-11-30(28-14-16-38(17-15-28)20-21-40-32-8-4-5-9-33(32)45-24-34(40)41)31(22-29)35(42)37-23-26-12-18-39(19-13-26)46(43,44)25-27-6-2-1-3-7-27/h1-11,22,26,28H,12-21,23-25H2,(H,37,42)
Show/Hide
|
||||||||||||||||||
InChIKey |
XFQMOGCLSPSWBG-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03174, Urotensin-2 receptor
Protein ID: PT02463, Urotensin-2 receptor